Neural Plasticity, 2019 · DOI: https://doi.org/10.1155/2019/9610687 · Published: February 18, 2019
Spinal cord injuries often lead to lasting sensorimotor dysfunction, impacting the quality of life. A key aspect of this injury involves the death of oligodendrocytes, cells responsible for myelinating axons, leading to demyelination. Promoting remyelination is a potential treatment strategy. MicroRNAs, like miR-219, are small RNA molecules that regulate gene expression. MiR-219 is known to influence the development of the central nervous system by affecting oligodendrocyte precursor cells (OPCs). This study investigates whether miR-219 can modulate OPC proliferation and differentiation after spinal cord injury. The study found that after spinal cord injury, miR-219 levels decreased, while the number of OPCs and astrocytes increased. Overexpressing miR-219 increased the number of oligodendrocytes and suppressed the generation of OPCs and astrocytes, suggesting miR-219 plays a role in mediating OPC behavior after SCI.
MiR-219 may represent a novel therapeutic target for promoting functional recovery after contusion spinal cord injury.
Upregulating miR-219 expression may promote remyelination after SCI.
Further research into the regulatory roles of miR-219 and MCT-1 in OPC proliferation and differentiation following SCI is warranted.